Abbott Vascular

TriMed Staff | March 24, 2009 | Cardiovascular Business | Patient Care


Abbott's Voyager NC balloon dilation catheter

Abbott Vascular (Booth 2761) is introducing its Xience V everolimus-eluting coronary stent system and its Voyager NC balloon dilation catheter for the treatment of coronary artery disease (CAD). The Xience V, the latest DES to become FDA-approved, releases everolimus, which has been shown to help prevent restenosis.

The Voyager NC is Abbott's next-generation balloon dilatation catheter for the treatment of CAD. The device was designed to restore blood flow in both pre-dilatation and post-dilatation procedures, and is available in several balloon diameters (from 2 mm to 5 mm) and lengths (from 6 mm to 25 mm). The Voyager NC is available on a rapid exchange delivery system.

TriMed Staff

Around the web

Radiology Business

Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Abbott Vascular

Related Content

Around the web